Samir Hanash

The University of Texas MD Anderson Cancer Center — United States

Immunology and Microbiology · Life Sciences

113h-index50.8kcitations1.3kworks1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

interferon and immune responses(150), Advanced Proteomics Techniques and Applications(142), PARP inhibition in cancer therapy(133), RNA modifications and cancer(130), Glycosylation and Glycoproteins Research(91)

Publications1.3k total

Abstract PS3-01-19: Supplemental Imaging Improves Breast Cancer Early Detection but Remains Underutilized among High-Risk Women
Clinical Cancer Research·2026
A Dual-Framework Approach for Improved Heart Disease Detection: CGAN-Based Data Augmentation and DAE Driven Feature Extraction
Engineering Technology & Applied Science Research·2025Open Access
Supplementary Figure 3 from SMAGS-LASSO: A Novel Feature Selection Method for Sensitivity Maximization in Early Cancer Detection
2025Open Access
Lung adenocarcinoma surfaceome remodeling with EGFR inhibitors uncovers placental alkaline phosphatase as a target for combination therapy
Cell Reports Medicine·2025· 1 citedOpen Access
Supplementary Figure 2 from SMAGS-LASSO: A Novel Feature Selection Method for Sensitivity Maximization in Early Cancer Detection
2025Open Access
Supplementary Table 1 from SMAGS-LASSO: A Novel Feature Selection Method for Sensitivity Maximization in Early Cancer Detection
2025Open Access
Supplementary Figure S18 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025Open Access
Supplementary Table S3 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
2025Open Access
Supplementary Figure S6 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025Open Access
Supplementary Table S4 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025Open Access
Supplementary Table S13 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025Open Access
Supplementary Figure S5 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025Open Access
Supplementary Figure S4 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025Open Access
Supplementary Figure S7 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025Open Access
Supplementary Table S5 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025Open Access
Supplementary Figure S15 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025Open Access
Supplementary Figure S8 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025Open Access
Supplementary Table S1 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025Open Access
Supplementary Table S11 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression
2025Open Access
Supplementary Table S1 from Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
2025Open Access
page 1 of 66Next →

Frequent Co-authors

David E. Misek(19), Rork Kuick(12), Thomas J. Giordano(11), Jeremy M. G. Taylor(8), David G. Beer(6), Dafydd G. Thomas(5), Kerby Shedden(5), Sharon L. R. Kardia(4), Guoan Chen(4), Tarek G. Gharib(4), Mark D. Iannettoni(4), Mark B. Orringer(4), Anirban Maitra(4), François Le Naour(4), Sophie Paczesny(4), Thomas Braun(4), Sung Won Choi(4), Pavan Reddy(4), John E. Levine(4), James L.M. Ferrara(4)